Klineo's €2M Boost for Cancer Patients
April 30, 2024, 9:31 am
French startup Klineo secures €2M to enhance access to clinical trials for cancer patients. Klineo's AI platform links doctors and patients to relevant trials, bridging the gap between research and treatment. With funding from BPI and angels, Klineo aims to cover all cancers in France by 2024 and expand globally. The platform's success lies in simplifying the search for trials, offering hope for patients and advancing medical research.